- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Veterinary Diagnostics
Snapshot for Heska Corp (HSKA)
| Open: | 7.9999 | Day's Range: | 7.8000 - 8.0000 | Volume: | 14,280 |
|---|---|---|---|---|---|
| Previous Close: | 8.0000 | 52wk Range: | 7.4500 - 12.9300 | 1-Yr Rtn: | -34.95% |
Key Statistics for HSKA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 64.2276 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 0.1230 |
| Est. PEG Ratio | 4.2818 |
| Market Cap (M USD) | 45.85 |
| Shares Outstanding (M) | 5.80 |
| 30 Day Average Volume | 18,126 |
| Price/Book (mrq) | 0.8824 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (USD) | - |
| Last Dividend | 02/25/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HSKA
Company Profile & Key Executives for HSKA
Heska Corporation discovers, develops, manufactures, and markets companion animal health products, primarily for dogs, cats, and horses. The Company also offers diagnostic and patient monitoring equipment, as well as diagnostic laboratory products in the United States and Europe.
| Robert B GrieveChairman/CEO/Co-Founder | Kevin WilsonPresident/COO |
| Michael J McGinley "Mike"President:Biologicals | Jason A NapolitanoExec VP/CFO/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HSKA News
-
Industry News
No stories found
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page